|
[1]
|
Association Testing of a Group of Genetic Markers Based on Next-Generation Sequencing Data and Continuous Response Using a Linear Model Framework
Mathematics,
2023
DOI:10.3390/math11061285
|
|
|
|
|
[2]
|
Comprehensive Pharmacology
2022
DOI:10.1016/B978-0-12-820472-6.00215-2
|
|
|
|
|
[3]
|
Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment
Genes,
2019
DOI:10.3390/genes10030191
|
|
|
|
|
[4]
|
Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment
Genes,
2019
DOI:10.3390/genes10030191
|
|
|
|
|
[5]
|
Quality control metrics improve repeatability and reproducibility of single-nucleotide variants derived from whole-genome sequencing
The Pharmacogenomics Journal,
2015
DOI:10.1038/tpj.2014.70
|
|
|
|
|
[6]
|
Likelihood-based complex trait association testing for arbitrary depth sequencing data
Bioinformatics,
2015
DOI:10.1093/bioinformatics/btv307
|
|
|
|
|
[7]
|
Comparing genetic variants detected in the 1000 genomes project with SNPs determined by the International HapMap Consortium
Journal of Genetics,
2015
DOI:10.1007/s12041-015-0588-8
|
|
|
|
|
[8]
|
Genomic Discoveries and Personalized Medicine in Neurological Diseases
Pharmaceutics,
2015
DOI:10.3390/pharmaceutics7040542
|
|
|
|
|
[9]
|
Likelihood-based complex trait association testing for arbitrary depth sequencing data
Bioinformatics,
2015
DOI:10.1093/bioinformatics/btv307
|
|
|
|
|
[10]
|
Genomic Discoveries and Personalized Medicine in Neurological Diseases
Pharmaceutics,
2015
DOI:10.3390/pharmaceutics7040542
|
|
|
|